MICHEL ANGE PROPHYL: Open Payments
NPI 1508577495 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,319 in 126 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $870 · 2025 $2,319
Food & beverage: $2,319
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $307 |
| Ardelyx, Inc. | 17 | $298 |
| ABBVIE INC. | 22 | $280 |
| Madrigal Pharmaceuticals | 13 | $278 |
| QOL Medical, LLC | 7 | $228 |
| Aimmune Therapeutics, Inc. | 12 | $156 |
| Celltrion USA Inc. | 3 | $82 |
| Biocon Biologics Inc | 2 | $50 |
| Gilead Sciences, Inc. | 2 | $49 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, Sucraid, ENTYVIO, EOHILIA, SKYRIZI, CREON.
Industry payments across FL — which companies pay providers there.
